SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-24-012587
Filing Date
2024-02-08
Accepted
2024-02-08 11:38:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G phibro_animal_hea_13g_de.htm SC 13G 97545
  Complete submission text file 0000950170-24-012587.txt   99241
Mailing Address 320 PARK AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address 320 PARK AVENUE, 8TH FLOOR NEW YORK NY 10022 212-355-1600
PZENA INVESTMENT MANAGEMENT LLC (Filed by) CIK: 0001027796 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88114 | Film No.: 24607734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)